Versant Capital Management, Inc Biotechnology

Versant Capital Management, Inc

$454 Million
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
MGTX Meira G Tx Holdings PLC	$283M	$2,000 0.0% of portfolio	425	Q4 2024 Added 124.87%
ARQT Arcutis Biotherapeutics, Inc.	$797M	$2,000 0.0% of portfolio	215	Q3 2024 New
RIGL Rigel Pharmaceuticals Inc	$3.93B	$2,000 0.0% of portfolio	123	Q4 2024 New
ROIV Roivant Sciences Ltd.	$7.54B	$2,000 0.0% of portfolio	207	Q4 2024 New
SRPT Sarepta Therapeutics, Inc.	$9.97B	$2,000 0.0% of portfolio	23	Q4 2024 Reduced 52.08%
VCYT Veracyte, Inc.	$3.26B	$2,000 0.0% of portfolio	68	Q2 2024 New
VNDA Vanda Pharmaceuticals Inc.	$249M	$2,000 0.0% of portfolio	571	Q4 2024 Added 2,279.17%
IONS Ionis Pharmaceuticals Inc	$4.56B	$1,000 0.0% of portfolio	55	Q4 2024 Reduced 12.7%
NTLA Intellia Therapeutics, Inc.	$725M	$1,000 0.0% of portfolio	150	Q4 2024 New
CRSP Crispr Therapeutics Ag	$3.12B	$1,000 0.0% of portfolio	35	Q3 2024 New
CORT Corcept Therapeutics Inc	$7.13B	$1,000 0.0% of portfolio	27	Q1 2024 Reduced 44.9%
KALV Kal Vista Pharmaceuticals, Inc.	$217M	$1,000 0.0% of portfolio	166	Q4 2024 New
BBIO Bridge Bio Pharma, Inc.	$5.07B	$1,000 0.0% of portfolio	38	Q3 2024 Reduced 72.86%
ADPT Adaptive Biotechnologies Corp	$1.11B	$1,000 0.0% of portfolio	332	Q4 2024 New
IGMS Igm Biosciences, Inc.	$43.7M	$1,000 0.0% of portfolio	169	Q3 2024 New
IOVA Iovance Biotherapeutics, Inc.	$923M	$1,000 0.0% of portfolio	202	Q3 2024 New
VRDN Viridian Therapeutics, Inc.\De	$795M	$1,000 0.0% of portfolio	82	Q4 2024 New
EWTX Edgewise Therapeutics, Inc.	$1.77B	$1,000 0.0% of portfolio	40	Q3 2024 New
VERV Verve Therapeutics, Inc.	$456M	$1,000 0.0% of portfolio	204	Q4 2024 Reduced 36.84%
SAGE Sage Therapeutics, Inc.	$431M	$1,000 0.0% of portfolio	236	Q4 2024 Reduced 31.79%
OCUL Ocular Therapeutix, Inc	$593M	$1,000 0.0% of portfolio	230	Q3 2024 New
MDXG Mimedx Group, Inc.	$988M	$1,000 0.0% of portfolio	203	Q4 2024 New
NKTR Nektar Therapeutics	$156M	$0 0.0% of portfolio	169	Q4 2023 Reduced 77.53%
VCEL Vericel Corp	$2.76B	$0 0.0% of portfolio	3	Q4 2024 New
EDIT Editas Medicine, Inc.	$90M	$0 0.0% of portfolio	100	Q3 2024 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.32B	$0 0.0% of portfolio	13	Q2 2023 New
RVMD Revolution Medicines, Inc.	$3.77B	$0 0.0% of portfolio	9	Q4 2024 New
TERN Terns Pharmaceuticals, Inc.	$177M	$0 0.0% of portfolio	36	Q4 2024 New
CYTK Cytokinetics Inc	$4.56B	$0 0.0% of portfolio	11	Q4 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$451M	$0 0.0% of portfolio	56	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.